UQ researchers move closer to developing topical cream for skin cancers in transplant patients

A topical cream to help prevent and treat skin cancers in organ transplant patients is a step closer to development.

Photobiomodulation in sleep has more therapeutic effects for Alzheimer’s disease than in wakefulness

It is well known that sleep is the best medication. However, it is still unknown why the brain recovers better in sleep and whether these

September 23, 2023

Refractory Multiple Myeloma Responsive to Immunotherapy Plus Low-Dose Radiotherapy

A third of patients with relapsed/refractory multiple myeloma responded to pembrolizumab (Keytruda) plus single-fraction radiotherapy (RT), a small clinical study showed. Results at 3 months

July 11, 2024

COMPASS Pathways announces publication of positive data from treatment-resistant depression phase 2 clinical trial of COMP360 psilocybin alongside antidepressants in Nature journal, Neuropsychopharmacology – Psychedelic Alpha

Results of COMPASS Pathways’ open-label study of COMP360 psilocybin treatment, alongside SSRI antidepressants, suggest that SSRIs do not interfere with the potential therapeutic effect of

July 17, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.